Your browser doesn't support javascript.
loading
Refinement of the critical 2p25.3 deletion region: the role of MYT1L in intellectual disability and obesity.
De Rocker, Nina; Vergult, Sarah; Koolen, David; Jacobs, Eva; Hoischen, Alexander; Zeesman, Susan; Bang, Birgitte; Béna, Frédérique; Bockaert, Nele; Bongers, Ernie M; de Ravel, Thomy; Devriendt, Koenraad; Giglio, Sabrina; Faivre, Laurence; Joss, Shelagh; Maas, Saskia; Marle, Nathalie; Novara, Francesca; Nowaczyk, Malgorzata J M; Peeters, Hilde; Polstra, Abeltje; Roelens, Filip; Rosenberg, Carla; Thevenon, Julien; Tümer, Zeynep; Vanhauwaert, Suzanne; Varvagiannis, Konstantinos; Willaert, Andy; Willemsen, Marjolein; Willems, Marjolaine; Zuffardi, Orsetta; Coucke, Paul; Speleman, Frank; Eichler, Evan E; Kleefstra, Tjitske; Menten, Björn.
Afiliación
  • De Rocker N; Center for Medical Genetics, Ghent University, Ghent, Belgium.
  • Vergult S; Center for Medical Genetics, Ghent University, Ghent, Belgium.
  • Koolen D; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Jacobs E; Center for Medical Genetics, Ghent University, Ghent, Belgium.
  • Hoischen A; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Zeesman S; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Bang B; Paediatric Department, Copenhagen University Hospital, Herlev, Denmark.
  • Béna F; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Bockaert N; Center for Developmental Disorders, Ghent University Hospital, Ghent, Belgium.
  • Bongers EM; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • de Ravel T; Center for Human Genetics, Leuven University Hospitals, KU Leuven, Leuven, Belgium.
  • Devriendt K; Center for Human Genetics, Leuven University Hospitals, KU Leuven, Leuven, Belgium.
  • Giglio S; Medical Genetics Unit, Meyer Children's University Hospital, Florence, Italy.
  • Faivre L; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital d'Enfants, CHU de Dijon, Dijon, France.
  • Joss S; West of Scotland Regional Genetics Service, NHS Greater Glasgow and Clyde, Southern General Hospital, Glasgow, UK.
  • Maas S; Department of Clinical Genetics, Academic Medical Center, UVA, Amsterdam, The Netherlands.
  • Marle N; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital d'Enfants, CHU de Dijon, Dijon, France.
  • Novara F; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Nowaczyk MJ; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Peeters H; Center for Human Genetics, Leuven University Hospitals, KU Leuven, Leuven, Belgium.
  • Polstra A; Department of Clinical Genetics, Academic Medical Center, UVA, Amsterdam, The Netherlands.
  • Roelens F; Heilig Hart Ziekenhuis Roeselare-Menen, Roeselare, Belgium.
  • Rosenberg C; Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, Brazil.
  • Thevenon J; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital d'Enfants, CHU de Dijon, Dijon, France.
  • Tümer Z; Center for Applied Human Molecular Genetics, Kennedy Center, University of Copenhagen, Glostrup, Denmark.
  • Vanhauwaert S; Center for Medical Genetics, Ghent University, Ghent, Belgium.
  • Varvagiannis K; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Willaert A; Center for Medical Genetics, Ghent University, Ghent, Belgium.
  • Willemsen M; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Willems M; Département de Génétique Clinique, CHRU de Montpellier, Hôpital Arnaud de Villeneuve, Montpellier, France.
  • Zuffardi O; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Coucke P; Center for Medical Genetics, Ghent University, Ghent, Belgium.
  • Speleman F; Center for Medical Genetics, Ghent University, Ghent, Belgium.
  • Eichler EE; Howard Hughes Medical Institute, University of Washington, Seattle, Washington, USA.
  • Kleefstra T; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Menten B; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Genet Med ; 17(6): 460-6, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25232846
ABSTRACT

PURPOSE:

Submicroscopic deletions of chromosome band 2p25.3 are associated with intellectual disability and/or central obesity. Although MYT1L is believed to be a critical gene responsible for intellectual disability, so far no unequivocal data have confirmed this hypothesis.

METHODS:

In this study we evaluated a cohort of 22 patients (15 sporadic patients and two families) with a 2p25.3 aberration to further refine the clinical phenotype and to delineate the role of MYT1L in intellectual disability and obesity. In addition, myt1l spatiotemporal expression in zebrafish embryos was analyzed by quantitative polymerase chain reaction and whole-mount in situ hybridization.

RESULTS:

Complete MYT1L deletion, intragenic deletion, or duplication was observed in all sporadic patients, in addition to two patients with a de novo point mutation in MYT1L. The familial cases comprise a 6-Mb deletion in a father and his three children and a 5' MYT1L overlapping duplication in a father and his two children. Expression analysis in zebrafish embryos shows specific myt1l expression in the developing brain.

CONCLUSION:

Our data strongly strengthen the hypothesis that MYT1L is the causal gene for the observed syndromal intellectual disability. Moreover, because 17 patients present with obesity/overweight, haploinsufficiency of MYT1L might predispose to weight problems with childhood onset.Genet Med 17 6, 460-466.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Cromosomas Humanos Par 2 / Deleción Cromosómica / Discapacidad Intelectual / Proteínas del Tejido Nervioso / Obesidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2015 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Cromosomas Humanos Par 2 / Deleción Cromosómica / Discapacidad Intelectual / Proteínas del Tejido Nervioso / Obesidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2015 Tipo del documento: Article País de afiliación: Bélgica